Patent ID: 7897566

Claim:
A compound according to the formula: (Aib 8,35 , Arg 26,34 , Phe 31 , Pro 37 , Ser 38,39 )hGLP-1(7-39)-NH 2 ; (SEQ ID NO:1) (Aib 8,35,37 , Arg 26,34 , Phe 31 , Asn 38 )hGLP-1(7-38)-NH 2 ; (SEQ ID NO:2) (Aib 8,35,37 , Arg 26,34 , Phe 31 , Ser 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:3) (Aib 8,35,37 , Gaba 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:4) (Aib 8,35,37 , Arg 26,34 , Phe 31 , His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:5) (Aib 8,35 , Arg 26,34 , Phe 31 , β-Ala 37 , His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:6) (Aib 8,35,37 , Arg 26,34 , D-His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:7) (Aib 8,35,37 , β-Ala 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:8) (Aib 8,35 , Arg 26,34 , β-Ala 37 , His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:9) (Aib 8,35,37 , Arg 26,34 , Phe 31 , Gly 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:10) (Aib 8,35,37 , Arg 26,34 , Gly 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:11) (Aib 8,35,37 , Arg 26,34 , β-Ala 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:12) (Aib 8,35,37 , Arg 26,34 , Gaba 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:13) (Aib 8,35,37 , Arg 34 , Phe 31 , His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:14) (Aib 8,35,37 , Arg 26,34 , His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:15) (Aib 8,35,37 , Arg 26,34 , Phe 31 , Gaba 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:16) (Aib 8,35,37 , Arg 34 , Phe 31 , D-His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:19) (Aib 8,35,37 , Arg 34 , Phe 31 , Gly 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:20) (Aib 8,35,37 , Gly 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:21) (Aib 8,35,37 , Arg 26,34 , Phe 31 , D-His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:22) (Aib 8,35 , Arg 26,34 , Phe 31 , β-Ala 37 , D-His 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:23) (Aib 8,35,37 , Arg 26,34 , Phe 31 , β-Ala 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:24) (Aib 8,35 , Arg 26,34 , Phe 31 , β-Ala 37,38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:25) (Aib 8,35,37 , Arg 34 , Phe 31 , β-Ala 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:26) or (Aib 8,35,37 , Arg 34 , Phe 31 , Gaba 38 )hGLP-1(7-38) NH 2 ; (SEQ ID NO:27) or a pharmaceutically acceptable salt thereof.